Decibel Cannabis Company Inc. (DB, DBCCF) announced the final closing of its private placement, raising $1.17 million to further integrate its recently acquired AgMedica BioScience. This follows a previous $2 million raise and positions Decibel for significant revenue growth in 2025.
Decibel Cannabis Company Inc. (DB:DBCCF) plans to raise up to $3.5 million through a non-brokered private placement of common shares. The funds will be used for general working capital purposes and to facilitate the integration of AgMedica BioScience Inc., which Decibel recently acquired. The offering is subject to regulatory approvals and is expected to close in one or more tranches by November 30, 2024.
Decibel Cannabis Company Inc. has announced the acquisition of AgMedica Bioscience Ltd., a move that significantly expands its international footprint and positions the company for substantial growth in 2025. The acquisition, facilitated through a $6.3 million convertible debenture, grants Decibel access to AgMedica’s EU GMP certified facility, paving the way for global cannabis product exports. This strategic move aligns with Decibel’s vision for profitable expansion through synergistic acquisitions.
Decibel Cannabis Company Inc. (DB, DBCCF) has reported exceeding expectations with its new flower strategy. The company’s QWEST brand, re-launched in July with a focus on affordable quality, has seen a significant increase in demand, both domestically and internationally. Despite recent sales declines, Decibel is making strategic moves to improve operational efficiency and achieve a free cash flow run rate of $10 million per year.
Decibel Cannabis Co. (DBCCF), a Canadian cannabis brand, is experiencing challenges in its core market segments, but is making strategic adjustments to regain market share. Despite recent sales declines, the company’s management is focused on stabilizing its core franchises and growing through a strategic re-entry into domestic recreational flower markets and increased exports. This strategic shift, combined with its compelling valuation, makes Decibel Cannabis an intriguing investment opportunity.
